Who owns AmeriPath?
AmeriPath is owned by Quest Diagnostics (the United States, NYSE: DGX).[1]
Evidence: Quest Diagnostics Incorporated Annual Report on Form 10-K filed 2026-02-26, SEC EDGAR, 26 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Quest Diagnostics Incorporated verified
- Owner HQ
- 🇺🇸 United States, Secaucus, New Jersey
- Origin
- 🇺🇸 United States
- Category
- Healthcare & pharma › Care providers › Labs & diagnostics
- Parent ticker
- NYSE: DGX
- Last verified
- · 1 sources
About AmeriPath
AmeriPath is the brand Quest Diagnostics uses for its anatomic pathology business, in which pathologists examine tissue samples to diagnose cancer and other disease. The 10-K lists it among the brands under which Quest provides services other than the Quest Diagnostics name, and says a senior executive took over the business in 2024.
How often Quest Diagnostics names AmeriPath in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named more often than it was three years earlier.
Ownership timeline of AmeriPath
- Current owner Quest Diagnostics [1] verified
Where AmeriPath sits in Quest Diagnostics
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Quest Diagnostics ownership tree →
See the full Quest Diagnostics brand portfolio (6) →
Other brands owned by Quest Diagnostics
Quest Diagnostics controls 6 brands on Brandtree, 5 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in labs & diagnostics, and who owns them
The 26 brands in labs & diagnostics on Brandtree belong to 6 owners. The largest is Sonic Healthcare, with 9; Quest Diagnostics has 5.
| Brand | Owner | Owner based in |
|---|---|---|
| Bioscientia | Sonic Healthcare | 🇦🇺 Australia |
| Al Borg | IDH | 🇪🇬 Egypt |
| Colilert | IDEXX | 🇺🇸 United States |
| Petrifilm | Neogen | 🇺🇸 United States |
| Labcorp | Labcorp | 🇺🇸 United States |
| Clinical Pathology Laboratories | Sonic Healthcare | 🇦🇺 Australia |
| Douglass Hanly Moir Pathology | Sonic Healthcare | 🇦🇺 Australia |
| Health Services Laboratories | Sonic Healthcare | 🇦🇺 Australia |
About the owner: Quest Diagnostics
Quest Diagnostics is a publicly listed company headquartered in Secaucus, New Jersey, United States. Brandtree records 6 brands under its control, and it is listed as NYSE: DGX.
Quest Diagnostics is a United States provider of diagnostic information services, running clinical laboratories and patient service centres and testing for physicians, hospitals, employers and insurers. Its 10-K says its services are mostly delivered under the Quest Diagnostics name, with AmeriPath, Dermpath Diagnostics, ExamOne and Quanum as other brands, and in 2024 it extended into Canada by buying LifeLabs.
Quest Diagnostics: full profile, brands and acquisition history →
🇺🇸 AmeriPath and other American brands
Brandtree records a controlling owner for 2,570 brands that began in the United States. 501 of them (19%) are now controlled by a company headquartered in another country; AmeriPath is not one of them.
Frequently asked questions
Who is the parent company of AmeriPath?
The parent company of AmeriPath is Quest Diagnostics, a publicly listed company headquartered in the United States.
Is AmeriPath American?
Yes. AmeriPath originated in the United States and its owner, Quest Diagnostics, is also headquartered in the United States.
Is AmeriPath still owned by Quest Diagnostics?
Yes. As of 29 October 2026, AmeriPath is still owned by Quest Diagnostics. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Quest Diagnostics Incorporated Annual Report on Form 10-K filed 2026-02-26 — SEC EDGAR, SEC Form 10-K, published 26 February 2026; retrieved 14 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.